{
  "chapter": "Endocrine Surgery-Breast-I",
  "questions": [
    {
      "q_no": 1,
      "question": "A 52-year-old female presents with a two-month history of persistent itching, redness, and scaling of the right nipple, unresponsive to moisturizing creams. Physical examination reveals erythema and crusting of the nipple and areola without palpable breast lumps. The image of her right breast is given below. What is the most probable diagnosis?",
      "options": {
        "A": "Paget disease of the nipple",
        "B": "Scirrhous tumor",
        "C": "Ductal papilloma",
        "D": "Inflammatory carcinoma"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Paget disease of the nipple Explanation: The given case scenario is that of Paget’s disease of the nipple Finding Description Possible Cause Nipple discharge Discharge from a single duct orifice Papilloma (Option C) or other underlying ductal disease Paget disease of the nipple Appears as a psoriatic rash starting on the nipple and spreading to the areola and breast skin. Paget disease Skin dimpling Traction on Cooper ligaments by a scirrhous tumor Best seen with angled indirect lighting during the abduction of the arms",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxsurgery/Endocrine_Surgery-Breast-I_Q1_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 2,
      "question": "A 45-year-old woman diagnosed with early-stage breast cancer opts for surgery that involves the removal of the entire breast, including the nipple and areola, but not the axillary lymph nodes. Which type of mastectomy is she likely undergoing?",
      "options": {
        "A": "Total (Simple) Mastectomy",
        "B": "Modified Radical Mastectomy",
        "C": "Radical Mastectomy",
        "D": "Extended Mastectomy"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer : A) Total (Simple) Mastectomy Explanation: Mastectomy: Surgical procedure to remove one or both breasts typically to treat or prevent breast cancer. Types of Mastectomy Types Structures removed Simple/Total mastectomy (Option A) En bloc removal of Nipple Areola Breast mass Skin Extended mastectomy (Total Mastectomy with Axillary Dissection) (Option D) Simple mastectomy + removal of level I axillary lymph nodes Halsted/Radical mastectomy (Option C) Simple mastectomy + removal of level I, II, III axillary lymph nodes + excision of pectoralis major and minor muscle. Modified Radical Mastectomy(MRM) (Option B) Simple mastectomy + removal of level I, II, III axillary lymph nodes Variants : Auchincloss modification : MRM Patey’s modification : MRM + excision of pectoralis minor Scanlons modification : MRM + division of pectoralis minor(removal and resuturing) Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Pages 935, 937. SRB's Manual of Surgery, 6th Edition, Pages 538-542.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 3,
      "question": "Which of the following conditions is not an absolute contraindication for breast-conserving surgery (BCS)?",
      "options": {
        "A": "Prior radiation therapy to the chest wall or breast",
        "B": "Diffuse malignant microcalcifications",
        "C": "Stage IIB breast cancer",
        "D": "Pregnancy"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Stage IIB breast cancer Explanation: Breast-conserving surgery (BCS), also known as lumpectomy, involves removing a breast tumor along with a small margin of surrounding healthy tissue while preserving the majority of the breast. The goal is to remove the cancerous cells while maintaining the breast's appearance and function. Performed for early invasive breast cancer (Stage I, IIA, IIB) Contraindications for breast-conserving surgery (BCS): Absolute Contraindications Pregnancy (Option D ruled out ) because after BCS postop radiotherapy will be necessary which is not possible in case pregnancy. Multicentric Disease Diffuse malignant microcalcifications on mammogram suggests widespread disease, making complete excision with clear margins unlikely ( Option B ruled out) Prior Radiation Therapy to the Chest Wall or Breast cannot give radiation again, which is essential after BCS (Option A ruled out) Extensive Positive Pathological Margins Relative Contraindications Active Connective Tissue Disease Involving the Skin (e.g., Scleroderma) Large tumor size relative to breast size or tumors greater than 5 cm Large pendulous breast Centrally located tumor Extensive DCIS (often requires aggressive management, such as mastectomy, due to the risk of recurrence). Homozygous for ATM Mutation Known or Suspected Li-Fraumeni Syndrome (p53 Mutation) Known or Suspected Genetic Predisposition to Breast Cancer (e.g., BRCA1, BRCA2) - Prophylactic mastectomy is preferred for individuals with high genetic cancer risk to reduce the likelihood of developing breast cancer. Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Pages 935, 936. Schwartz's Principles of Surgery, 11th Edition, Page 591. Sabiston Textbook of Surgery, 21st Edition, Pages 843, 844. https://www.ncbi.nlm.nih.gov/books/NBK547708",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 4,
      "question": "Which of the following are components of the Van Nuys Prognostic Index (VNPI) for DCIS? Tumor size Margin status Histological grade Patient age",
      "options": {
        "A": "1 & 2",
        "B": "1 & 3",
        "C": "1, 2 & 3",
        "D": "1, 2, 3 & 4"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) 1, 2, 3 & 4 Explanation: Van Nuys Prognostic Index (VNPI) for Ductal Carcinoma In Situ (DCIS) Factor Score 1 Score 2 Score 3 Tumor Size ≤ 15 mm 16-40 mm >40 mm Margin Status >10 mm 1-9 mm <1 mm Histological Grade Grade I/II Well-differentiated Necrosis absent Grade I/II Moderately differentiated Necrosis present Grade III Poorly differentiated Necrosis present Patient Age > 61 years 40-60 years < 39 years VNPI Score Calculation The VNPI score is the sum of points from all four factors. The total score is used to stratify the risk and guide treatment decisions Total Score 4-6: Low risk Total Score 7-9: Intermediate risk Total Score 10-12: High risk Reference: SRB's Manual of Surgery, 6th Edition, Page 524.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 5,
      "question": "Which of the following describes the basal type of breast malignancy?",
      "options": {
        "A": "ER +, PR -, and HER2 +",
        "B": "ER -, PR -, and HER2 -",
        "C": "ER +, PR +, and HER2 +",
        "D": "ER -, PR -, and HER2 +"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) ER-, PR-, and HER2 neu- Explanation: Molecular classification of breast cancer Subtype ER Status PR Status HER2 Status Ki-67 Status Characteristics Luminal A + + - Low Generally low grade, better prognosis, responsive to hormonal therapy. Luminal B + + or - + or - High Higher grade, poor prognosis compared to Luminal A, may require targeted HER2 therapy following status. HER2-enriched - - + High Aggressive, higher grade, poor prognosis, requires targeted HER2 therapy. Basal-like - - - High Includes triple-negative breast cancer (TNBC), highly aggressive, no targeted hormonal therapy. Claudin-low - - + or - Often High Often associated with poor prognosis and aggressive behavior, typically lacks response to hormonal therapy. Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Page 931. SRB's Manual of Surgery, 6th Edition, Page 533.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 6,
      "question": "A 55-year-old woman presents with a palpable breast lump. After imaging studies and a biopsy, the results show a tumor measuring 3.5 cm in the breast. The patient also has involvement of ipsilateral internal mammary lymph nodes, but no distant metastases are detected. Based on the TNM staging system, what is the appropriate stage for this breast cancer?",
      "options": {
        "A": "T1 N2",
        "B": "T2 N1",
        "C": "T2 N2",
        "D": "T3 N1"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) T2 N2 Explanation: (T2 N2) The tumor size of 3.5 cm fits the T2 category (tumor > 2.0 cm but ≤ 5.0 cm). The involvement of ipsilateral internal mammary lymph nodes is classified as N2, and no distant metastases (M0) are present. TNM staging for breast cancer Stage Description Tumor size (T) TX Primary tumor cannot be assessed T0 No evidence of primary tumor Tis Carcinoma in situ (DCIS, LCIS, or Paget's disease) T1 Tumor ≤ 2 cm T1mi Tumor ≤ 1 mm T1a Tumor > 1 mm but ≤ 5 mm T1b Tumor > 5 mm but ≤ 10 mm T1c Tumor > 10 mm but ≤ 20 mm T2 Tumor > 2 cm but ≤ 5 cm T3 Tumor > 5 cm T4 Tumor of any size with direct extension to chest wall or skin T4a Extension to chest wall T4b Ulceration or skin nodules T4c Both T4a and T4b T4d Inflammatory breast cancer Node (N) NX Regional lymph nodes cannot be assessed N0 No regional lymph node metastasis N1 Metastases to movable ipsilateral level I, II axillary lymph nodes N2 Metastasis to axillary lymph nodes or clinically apparent internal mammary nodes N2a Metastasis to axillary lymph nodes that are clinically fixed or matted N2b Metastasis to internal mammary nodes without axillary lymph node involvement N3 Metastasis to axillary lymph nodes or infraclavicular nodes, or to supraclavicular nodes N3a Metastasis to infraclavicular nodes N3b Metastasis to internal mammary nodes N3c Metastasis to supraclavicular nodes Metastasis (M) MX Distant metastasis cannot be assessed M0 No distant metastasis M1 Distant metastasis present Stage Grouping Stage 0: Tis N0 M0 Stage IA: T1/T1mi N0 M0 Stage IB: T0 N1mi M0; T1/T1mi N1mi M0 Stage IIA: T0 N1 M0; T1 N1 M0; T2 N0 M0 Stage IIB: T2 N1 M0; T3 N0 M0 Stage IIIA: T0 N2 M0; T1 N2 M0; T2 N2 M0; T3 N1 M0 Stage IIIB: T3 N2 M0 Stage IIIC: T4 N0 M0; T4 N1 M0; T4 N2 M0; Any T N3 M0 Stage IV: Any T Any N M1 Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Page 934. Sabiston Textbook of Surgery, 21st Edition, Page 833. SRB's Manual of Surgery, 6th Edition, Page 532.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 7,
      "question": "A 45-year-old woman presents for her routine mammogram. She has no family history of breast cancer and no previous history of breast issues. A mammogram reveals a well-circumscribed, homogeneous lesion with characteristic benign features, such as a simple cyst with no suspicious calcifications or architectural distortions. Based on these findings, What is the appropriate BI-RADS category for this lesion?",
      "options": {
        "A": "BI-RADS 1",
        "B": "BI-RADS 2",
        "C": "BI-RADS 3",
        "D": "BI-RADS 4"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) BI-RADS 2 Explanation: The scenario describes a well-circumscribed, homogeneous lesion with characteristic benign features, such as a simple cyst with no suspicious calcifications or architectural distortions. This suggests lesion is Benign and so BIRADS 2 is the appropriate score for this situation. BI-RADS Score: BI-RADS Category Description Management Likelihood of Malignancy 0 Incomplete Need additional imaging evaluation N/A 1 Negative Routine screening Essentially 0% 2 Benign Routine screening Essentially 0% 3 Probably Benign Short-term follow-up (6 months) < 2% 4 Suspicious of Malignancy Biopsy should be considered 4A Suspicious: Low _ > 2% to ≤ 10% 4B Suspicious: Moderate _ > 10% to ≤ 50% 4C Suspicious: High _ > 50% to ≤ 95% 5 Highly Suggestive of Malignancy Appropriate action should be taken > 95% 6 Known Biopsy-Proven Malignancy Appropriate action should be taken 100% Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Page 917. Sabiston Textbook of Surgery, 21st Edition, Page 821 SRB's Manual of Surgery, 6th Edition, Page 507.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 8,
      "question": "Match the following: Biopsy Feature 1. FNAC a. Evaluation of cellular fibroadenoma 2. Core-needle biopsy b. Assessment of suspicious lymph nodes 3. Excisional biopsy c. Sampling solid masses, calcifications, and densities identified on imaging",
      "options": {
        "A": "1-b,2-c,3-a",
        "B": "1-a,2-b,3-c",
        "C": "1-c,2-b,3-a",
        "D": "1-b,2-a,3-c"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) 1-b,2-c,3-a Explanation: Biopsy Type Description Indications Limitations Fine-needle aspiration (FNA) 22-gauge needle Evaluation of secondaries Assessment of suspicious lymph nodes Cannot differentiate between noninvasive and invasive lesions if malignant cells are found Requires core needle biopsy (CNB) for definitive histologic diagnosis May yield inconclusive results Core Needle Biopsy (CNB) Preferred method Imaging guidance Needle: 8 to 14-gauge Sampling solid masses, calcifications, and densities identified on imaging Used to obtain histologic subtype, grade, and receptor status of detected malignancies Small sample size requires careful interpretation Inconclusive results may necessitate surgical excision Excisional Biopsy Entire lesion removed for diagnosis Used when CNB results are inconclusive or when there is discordance with imaging findings Evaluation of atypical ductal hyperplasia (ADH) or cellular fibroadenoma Costly Delays definitive treatment More invasive Reference: Sabiston Textbook of Surgery, 21st Edition, Pages 816, 817. Bailey & Love's Short Practice of Surgery, 28th Edition, Page 918 SRB's Manual of Surgery, 6th Edition, Pages 534, 535.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 9,
      "question": "A 48-year-old female underwent a lumpectomy for a 2 cm invasive ductal carcinoma in her right breast. Post-surgery pathology revealed positive margins, indicating residual cancerous tissue. Which of the following investigations is most suitable to check for residual cancer tissues?",
      "options": {
        "A": "MRI",
        "B": "USG",
        "C": "Mammography",
        "D": "Repeat the biopsy"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) MRI Explanation: MRI is preferred for checking for residual disease after lumpectomy with positive margins. Magnetic Resonance Imaging (MRI) in breast cancer Indications: Tumors in patients with axillary lymph node metastases and no mammographic evidence Paget disease of the nipple without radiographic evidence of a primary tumor The extent of the primary tumor, especially in young women with dense breast tissue Residual disease after lumpectomy with positive margins Screening the contralateral breast Invasive lobular cancers After neoadjuvant chemotherapy Assessing implant rupture or evaluating the breast after silicone injection American Cancer Society Recommendations Annual MRI screening starting at age 30 for women with a high lifetime risk (20%-25% or greater) Women with a moderately increased risk (15%-20%) should discuss benefits and limitations with their physicians Not recommended for women with a lifetime risk of less than 15% Used in addition to screening mammography, not as a replacement Ultrasonography (USG) in breast cancer Uses Determines if a lesion detected by mammography is solid or cystic Discriminating lesions in dense breasts Limitations Not effective as a standalone breast cancer screening tool Highly dependent on the operator performing the scan Lack of standardized screening protocols Reference: Sabiston Textbook of Surgery, 21st Edition, Pages 818-819 Bailey & Love's Short Practice of Surgery, 28th Edition, Pages 915, 916, 917. SRB's Manual of Surgery, 6th Edition, Pages 534, 537.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 10,
      "question": "A lesion was found in a routine mammogram of a 52-year-old asymptomatic woman. Which of the following statements regarding mammogram findings is false?",
      "options": {
        "A": "If the density of the lesion is high, it is mostly malignant",
        "B": "Architectural distortion is usually present in benign lesions",
        "C": "Calcification in benign lesions is diffuse",
        "D": "Margins are well-circumscribed in benign lesions"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Architectural distortion is usually present in benign lesions Explanation: Architectural distortion is usually present in malignant lesions, not benign lesions Mammography findings Feature Benign Lesions Malignant Lesions Shape Round, oval, lobular Irregular Margins Circumscribed Microlobulated, obscured, indistinct, spiculated Density Low to intermediate Intermediate to high Distribution of Calcifications Randomly distributed, diffuse Grouped, clustered, fine linear, branching, segmental Architectural Distortion Usually absent Often present Mammography Purpose of Screening Detect occult breast cancer in asymptomatic women Benefits Early detection Reduced mortality High sensitivity and specificity in older women (fatty breast tissue) Disadvantages Screening expenses False positives Additional workups Anxiety (USPSTF) Recommendations Biennial screening for women 50-74 years Recommended against screening for women 40-49 years and >75 years. American Cancer Society Recommendations Annual screening for women >40 years in good health MRI screening for younger women with high risk (20% lifetime risk) Reference: https://www.ncbi.nlm.nih.gov/books/NBK12642/#:~:text=The%20most%20significant%20features%20th at,a%20greater%20likelihood%20of%20malignancy . Sabiston Textbook of Surgery, 21st Edition, Pages 817, 818. Bailey & Love's Short Practice of Surgery, 28th Edition, Page 916, 917. SRB's Manual of Surgery, 6th Edition, Pages 533, 534.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 11,
      "question": "A 45-year-old female presents with a painless lump in her right breast, noticed during a self-examination two weeks ago. Which of the following tests has the maximum accuracy?",
      "options": {
        "A": "FNAC",
        "B": "Core biopsy",
        "C": "Mammography",
        "D": "Triple assessment"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Triple assessment Explanation: Triple assessment is a combination of assessment used for breast cancer screening and diagnosis Triple Assessment of Breast Examination 1. Clinical Examination Objective: Identify lumps, skin changes, nipple discharge, or lymphadenopathy. Procedure: Palpation of breasts and lymph nodes. 2. Imaging Methods: Mammography: Preferred for women over 40. Ultrasound: Used in younger women or for further evaluation. 3. Biopsy Types: FNA: Minimally invasive; used for cystic lesions. Core Needle: Preferred for solid masses. Excisional: Removes lump for examination. Triple assessment yields more accurate results in comparison to using individual assessment. Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188022/ Bailey & Love's Short Practice of Surgery, 28th Edition, Page 915. SRB's Manual of Surgery, 6th Edition, Page 538.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 12,
      "question": "Which of the following statements about lymphatic drainage of the breast is true?",
      "options": {
        "A": "Level III lymph nodes are located lateral to the pectoralis minor muscle.",
        "B": "Lymphatic drainage from the breast is directed to the subclavian lymph nodes.",
        "C": "Level I lymph nodes are also known as rotter’s nodes.",
        "D": "Level II lymph nodes are located posterior to the pectoralis major"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Level II lymph nodes are located posterior to the pectoralis major Explanation: Axillary lymph nodes are categorized into three anatomical levels based on their relationship to the pectoralis minor muscle. Level of node Location Level I Lateral to the lateral border of pectoralis minor Level II(Rotter/Interpectoral nodes) Anterior as well as posterior to the pectoralis minor and posterior to the pectoralis major. Level III Medial to the pectoralis minor muscle and include subclavicular nodes The functional anatomy of these lymph nodes helps in preventing lymphedema during lymphadenectomy for breast cancer. Lymphatic drainage of the breast is predominant in axillary lymph nodes Level III lymph nodes are located medial to the pectoralis minor muscle and include the subclavicular nodes. (Option A) Majority of lymphatic drainage from the breast is directed to the axillary lymph nodes and collects under nipple and areola forming sappey plexus, not the subclavian lymph nodes. (Option B) Level II lymph nodes are known as rotter’s or interpectoral nodes and not Level I nodes. (Option C)",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxsurgery/Endocrine_Surgery-Breast-I_Q12_exp.png",
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 13,
      "question": "Arrange the following in decreasing order of frequency of metastasis in breast cancer",
      "options": {
        "A": "Lumbar vertebrae> femur> thoracic vertebrae> ribs> skull",
        "B": "Lumbar vertebrae> thoracic vertebrae> ribs> skull> femur",
        "C": "Thoracic vertebrae>lumbar vertebrae> ribs> skull> femur",
        "D": "Thoracic vertebrae> femur> lumbar vertebrae> ribs> skull"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Lumbar vertebrae> femur> thoracic vertebrae> ribs> skull Explanation: Spread of breast cancer Local Invasion Tumors invade nearby tissues (skin, chest wall). Inflammatory breast cancer blocks lymphatic vessels(subdermal /superficial), causing peau d'orange, often without a palpable mass, complicating detection. Lymphatic Spread Cancer cells spread to nearby lymph nodes Positive nodes indicate worse prognosis Axillary nodes (75% drainage)- Axillary nodes: Level I (lateral), Level II (posterior), Level III (medial). Lymph nodes closest to the tumor (level I) are usually affected first, followed by those in the middle (level II) and then the top of the armpit (level III). Internal mammary lymph nodes (5% drainage) - secondary route in 20% of cases. Hematogenous Spread Cancer cells enter the bloodstream indicating stage IV cancer. Metastasising to distant organs in frequency : Bones> lungs> liver> brain Among bones frequency: Lumbar vertebrae> femur> thoracic vertebrae> ribs> skull (Option A) Multifocal Growth Cancers may appear as multiple independent foci within the same breast or different quadrants Common in invasive lobular carcinoma. Reference: Sabiston Textbook of Surgery, 21st Edition, Pages 810 ,832 Bailey & Love's Short Practice of Surgery, 28th Edition, Page 932 Schwartz's Principles of Surgery, 11th Edition, Page 563",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 14,
      "question": "A 55-year-old woman is diagnosed with breast cancer. The pathology report shows a 2.5 cm tumor with positive lymph nodes. The tumor is ER-positive, PR-positive, and HER2-negative. Which of the following statements is most accurate regarding her prognosis and treatment?",
      "options": {
        "A": "The tumor size and lymph node status suggest a favorable prognosis",
        "B": "The hormone receptor status indicates the tumor will not respond to endocrine therapy",
        "C": "The absence of HER2 overexpression means targeted therapies are the primary treatment option",
        "D": "The ER-positive status suggests a better prognosis and responsiveness to endocrine therapy"
      },
      "correct_answer": "D",
      "explanation": "endocrine therapy Correct Answer: D) The ER-positive status suggests a better prognosis and responsiveness to endocrine therapy Explanation: Disease factors that influence prognosis Histologic Subtypes Invasive Ductal Carcinoma (IDC): Prognosis varies by grade and molecular markers. Invasive Lobular Carcinoma (ILC): Intermediate prognosis. Tubular and Mucinous Carcinomas: Best prognosis. Basal-like Breast Cancer: Aggressive, triple-negative, no targeted treatments. Other Subtypes: Medullary, cribriform, papillary, adenoid cystic, metaplastic carcinomas vary in prognosis. Tumor Size & Lymph Node Pathologic staging (tumor size, lymph nodes) guides prognosis and treatment. Larger tumors and positive lymph nodes = worse prognosis. (Option A) Molecular Markers Hormone Receptors (ER, PR): ER-positive = better prognosis (Option D) , responsive to endocrine therapy. (Option B) HER-2 Status: HER-2 positive = aggressive but treatable with targeted therapies. (Option C) Patient factors that influence prognosis Age Younger, particularly premenopausal women, may have higher local recurrence rates post-surgery, but radiation therapy can reduce this risk. BRCA Mutation Generally more aggressive and associated with poorer prognosis. Family History A strong family history may indicate inherited susceptibility and potentially worse prognosis. Prior Breast Cancer History Previous breast cancer can negatively influence the prognosis of a new diagnosis. Lifestyle Factors Obesity and inactivity are linked to increased recurrence risk and may affect overall prognosis. Treatment Adherence Non-compliance can worsen prognosis. Tumor Characteristics: 2.5 cm size and positive lymph nodes suggest advanced stage, but hormone receptor positivity improves outlook. (Option A) Hormone Receptor Status- ER/PR-positive tumors respond well to endocrine therapies, generally indicating better prognosis. (Option B) HER2 Status- Negative excludes HER2-targeted therapies, but doesn't affect endocrine therapy effectiveness. (Option C) Reference: Sabiston Textbook of Surgery, 21st Edition, Pages 828, 829, 831, 832, 835, 839, 847, 851 Bailey & Love's Short Practice of Surgery, 28th Edition, Page 942",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 15,
      "question": "A 38-year-old premenopausal woman is diagnosed with Lobular Carcinoma In Situ (LCIS) after a breast biopsy. She opts for chemoprevention as her management strategy. Her doctor discusses various medication options with her. Which of the following statements about chemoprevention for LCIS is correct?",
      "options": {
        "A": "Chemoprevention eliminates the risk of developing breast cancer",
        "B": "Tamoxifen reduces breast cancer risk by 25% over 5 years",
        "C": "Chemoprevention is only effective for the ipsilateral breast",
        "D": "Tamoxifen reduces breast cancer risk by 56% over 5 years"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Tamoxifen reduces breast cancer risk by 56% over 5 years. Explanation: Lobular Carcinoma In Situ (LCIS) Overview Histologic marker of increased breast cancer risk, not true cancer. It involves an abnormal proliferation of cells within the lobules of the breast without invasion through the basement membrane. Subsequent invasive cancers are predominantly ductal, not lobular Characteristics Occurs mainly in younger, premenopausal women Typically an incidental finding during biopsy No palpable masses or suspicious mammographic microcalcifications Bilateral Risk 21.4% chance of developing carcinoma over 35 years 7:1 risk ratio for invasive breast cancer 50% of subsequent carcinomas in contralateral breast Management Close observation Chemoprevention Medications: Tamoxifen, Raloxifene, or Arimidex Tamoxifen reduces risk by 56% over 5 years Surgical: Bilateral mastectomy (if surgery chosen prophylactically) Clinical Significance Lifelong breast cancer risk affecting both breasts equally Risk slightly less than 1% per year Reference: Sabiston Textbook of Surgery, 21st Edition, Pages 821, 827, 828 Schwartz's Principles of Surgery, 11th Edition, Pages 563, 564. SRB's Manual of Surgery, 6th Edition, Page 526.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 16,
      "question": "A 52-year-old woman undergoes a routine mammogram, which reveals clustered calcifications in her left breast. Further investigation confirms the diagnosis of ductal carcinoma in situ (DCIS). The lesion is small, low-grade, and has clear margins. The patient expresses a strong desire to preserve her breast if possible. What is the most appropriate initial treatment approach?",
      "options": {
        "A": "Hormonal therapy alone",
        "B": "Lumpectomy with radiation therapy",
        "C": "Lumpectomy alone",
        "D": "Systemic chemotherapy"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Lumpectomy alone. Explanation: Given that the DCIS is small, low-grade, and has clear margins the scenario describes a low-risk case. Considering the patient's desire for breast preservation, breast-conserving surgery (Lumpectomy) alone is appropriate. Ductal Carcinoma in situ (DCIS) Overview Non-invasive breast cancer within milk ducts Does not spread beyond the ductal membrane into the surrounding tissue Detection Primarily through mammogram (clustered calcifications) Less common: palpable mass, calcifications with density, nipple discharge Types of DCIS Papillary (Low grade) Cribriform (Low grade) Solid (High grade) Comedo (High grade) Mixed morphology- Most DCIS lesions have Treatment Mastectomy Near-certain cure rate (98-99% survival) 1-2% lifetime risk of local recurrence Breast-conserving surgery (lumpectomy) with radiation Reduces recurrence risk compared to lumpectomy alone (Option B) Breast-conserving surgery alone For specific low-risk cases (Option C) Adjuvant Therapies Hormonal therapy (e.g., Tamoxifen) (Option A) Sentinel lymph node biopsy (SLNB) Recommended for mastectomy patients Considered in specific breast-conserving surgery cases Reference: Sabiston Textbook of Surgery, 21st Edition, Pages 827, 828. Schwartz's Principles of Surgery, 11th Edition, Pages 564, 565. SRB's Manual of Surgery, 6th Edition, Page 52",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 17,
      "question": "All of the following are invasive carcinomas except:",
      "options": {
        "A": "Ductal carcinoma",
        "B": "Lobular carcinoma",
        "C": "Tubular carcinoma",
        "D": "Fibroadenoma"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Fibroadenoma Explanation Classification of breast cancer Invasive Carcinomas Invasive Carcinoma of No Special Type (NST) Special Subtypes of Invasive Carcinoma: Invasive Ductal carcinoma (Option A) Invasive Lobular Carcinoma: Classic, solid, alveolar, pleomorphic, and tubulolobular variants. (Option B) Tubular Carcinoma Cribriform Carcinoma Mucinous Carcinoma: Characterized by mucin production, good prognosis. Medullary Carcinoma: Lymphoplasmacytic infiltrate, associated with BRCA1 mutations. (Option C) Metaplastic Carcinoma Invasive Micropapillary Carcinoma Carcinomas with Apocrine Differentiation Precursor Lesions Ductal Carcinoma In Situ (DCIS) Lobular Carcinoma In Situ (LCIS) Benign Epithelial Proliferations Fibroadenomas (Option D) Phyllodes Tumors Rare Tumor Types Adenoid Cystic Carcinoma Secretory Carcinoma Reference: Sabiston Textbook of Surgery, 21st Edition, Page 828 Bailey & Love's Short Practice of Surgery, 28th Edition, Page 931 Schwartz's Principles of Surgery, 11th Edition, Page 566 classification 1 Classification 2 tubular carcinoma 1 tubular carcinoma 2 tubular carcinoma 3",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 18,
      "question": "Which of the following is the most common model used for breast cancer risk assessment?",
      "options": {
        "A": "Gail Model",
        "B": "Framingham Risk Score",
        "C": "ASCVD Risk Estimator",
        "D": "QRISK3"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Gail Model Explanation: Risk assessment models of breast carcinoma Two main models are used Gail model Clause model Gail model Clause model Most commonly used More information about family history Absolute risk estimation Relative risk estimation It is assessed with Age at menarche Number of 1st°relatives with breast carcinoma Age at first life birth Number of breast biopsies It is assessed with 1st° and 2nd° relatives with breast cancer Age of diagnosis of relatives Other models are: CARE model: Specifically developed for African-Americans Couch model: Predicts risk for mutation in BRCA1 gene Tyrer-Cuzick model: Incorporates Personal risk factors and genetic analysis Framingham Risk Score (Option B): Primarily used for assessing the risk of cardiovascular disease, not breast cancer. ASCVD Risk Estimator (Option C): Used to assess the risk of atherosclerotic cardiovascular disease, not breast cancer. QRISK3 (Option D): Model used to predict the risk of cardiovascular disease, not breast cancer. Reference: Sabiston Textbook of Surgery, 21st Edition, Pages 823, 824. Schwartz's Principles of Surgery, 11th Edition, Page 555. SRB's Manual of Surgery, 6th Edition, Page 523.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 19,
      "question": "Which of the following statements about breast cancer risk factors is true?",
      "options": {
        "A": "The median age of breast cancer presentation is 60 years in India",
        "B": "The relative risk of Papillomatosis is 8-10",
        "C": "Relative Risk for breast cancer in 1st-degree relative is 3",
        "D": "Early onset of menstruation increases breast cancer risk."
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Early onset of menstruation increases breast cancer risk. Explanation : Risk factors for breast cancer Modifiable risk factors Non-modifiable risk factors Obesity: BMI > 30 (RR= 1.29) Age Median age at presentation is 60 years in the West(UK,USA) While it is around 48 years in low/middle-income nations such as India.(Option A) Nulliparous women or first pregnancy after 35 years Sex Female sex is a risk factor Male sex accounts for 0.5-1% of all breast cancer Breastfeeding is a protective factor Ethnicity American white, African-American Parsi in India Use of Hormonal Replacement Therapy (HRT) >10 years (RR= 1.2) Family history of breast cancer 1 first degree relative RR= 2(option C) 2 first-degree relative RR= 3 Tobacco use (RR=1.07-1.14) Genetic predisposition BRCA1 and BRCA2 mutations account for 70% of hereditary breast cancers Alcohol Consumption (RR = 1.05-1.32) Early Menarche(<12years) Increases by around 5% for each year earlier menstruation begins RR=1.19 Radiation exposure (RR=6) Late Menopause(>55years) Increases by about 3% for each year later menopause begins RR=1.12 Age at first child <20years - Less risk >35years - High risk High-risk breast lesions Complex fibroadenoma RR=3 Papillomatosis RR=3(Option B) Ductal and lobular hyperplasia RR= 5 Lobular carcinoma in situ RR= 8-10 Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Pages 930, 931. Schwartz's Principles of Surgery, 11th Edition, Pages 555, 556. SRB's Manual of Surgery, 6th Edition, Page 523.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 20,
      "question": "Which of the following is the most common cause of bloody nipple discharge?",
      "options": {
        "A": "Breast cancer",
        "B": "Fibroadenoma",
        "C": "Intraductal papilloma",
        "D": "Duct Ectasia"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Intraductal papilloma Explanation: Intraductal papilloma: A benign tumor that forms in a milk duct in the breast. It is the most common cause of bloody nipple discharge. Symptoms : The most common cause of Nipple discharge (often clear or bloody), a palpable lump near the nipple. Causes : Age (35-55 years) Longtime exposure to estrogen Family history of breast cancer Diagnosis : Clinical breast examination Imaging: Mammography and ultrasound Biopsy to rule out malignancy. Treatment : Surgical removal of the papilloma and the affected duct and monitoring for any signs of recurrence. Nipple Discharge Type of Nipple Discharge Causes Bloody Intraductal Papilloma (Most Common) Breast Carcinoma Duct Ectasia Serous Fibrocystic Disease (Most Common) Breast Carcinoma Duct Ectasia Greenish/Blackish Duct Ectasia Milk (Galactorrhea) Physiological (e.g., Pregnancy, Lactation) Hyperprolactinemia (e.g., Pituitary Adenoma, Hypothyroidism) Medications (e.g., Antipsychotics, Antidepressants, Oral Contraceptives) Purulent Breast Abscess Mastitis Breast cancer (Option A): Both ductal carcinoma in situ (DCIS) and invasive ductal carcinoma can present with bloody discharge. However, this is not the most common cause as compared to intraductal papilloma. Fibroadenoma (Option B): Benign breast tumors that are most common in young women. They are usually painless, firm, and mobile lumps within the breast. Fibroadenomas do not typically cause bloody nipple discharge Duct ectasia (Option D): Inflammation and dilation of the ducts, which can sometimes cause bloody discharge. However, this is not the most common cause as compared to intraductal papilloma. Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Page 924. SRB's Manual of Surgery, 6th Edition, Page 556.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Endocrine Surgery-Breast-I"
    },
    {
      "q_no": 21,
      "question": "What is the primary arterial supply to the superior part of the breast?",
      "options": {
        "A": "Internal thoracic artery",
        "B": "Lateral thoracic artery",
        "C": "Thoracoacromial artery",
        "D": "Intercostal artery"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Thoracoacromial artery Explanation: Artery Areas Supplied Internal thoracic artery Medial and central parts of the breast Lateral thoracic artery Lateral aspect of the breast Thoracoacromial artery Superior part of the breast Posterior intercostal arteries Lateral and posterior aspects of the breast Superior thoracic artery Upper part of the breast (limited supply) Subscapular artery Lower part of the breast Reference: Gray’s Anatomy, 42nd Edition, Pages 1014, 1015. SRB's Manual of Surgery, 6th Edition, Page 506. https://www.ncbi.nlm.nih.gov/books/NBK519575/",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxsurgery/Endocrine_Surgery-Breast-I_Q21_exp.jpg",
      "chapter_heading": "Endocrine Surgery-Breast-I"
    }
  ]
}
